This statistic shows the earnings before interest, tax, depreciation and amortization (EBITDA) of from calendar year 2013 to fiscal year 2018. In fiscal year 2019, Glaxo Smith Kline Pharmaceuticals Limited in India had around 6.31 billion Indian rupees as earnings before interest, tax, depreciation and amortization. This was an increase compared to the previous fiscal year's 5.1 billion rupees worth EBITDA.
EBITDA of GSK Pharmaceuticals Limited in India from CY 2013 to FY 2019 (in billion Indian rupees)*
*Earnings before interest, tax, depreciation and amortization (EBITDA) for the year 2017-18, year 2016-17, year 2015-16 and 15 months ended March 2015 were as per Ind Accounting Standards.
One Indian rupee is equal to 0.013 euros and 0.014 U.S. dollars (as of November 2019).
India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Statistics on "Pharmaceutical brands: Advair/Seretide (GlaxoSmithKline)"
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
GlaxoSmithKline. (June 18, 2019). EBITDA of GSK Pharmaceuticals Limited in India from CY 2013 to FY 2019 (in billion Indian rupees)* [Graph]. In Statista. Retrieved April 04, 2020, from https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "EBITDA of GSK Pharmaceuticals Limited in India from CY 2013 to FY 2019 (in billion Indian rupees)*." Chart. June 18, 2019. Statista. Accessed April 04, 2020. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. (2019). EBITDA of GSK Pharmaceuticals Limited in India from CY 2013 to FY 2019 (in billion Indian rupees)*. Statista. Statista Inc.. Accessed: April 04, 2020. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "Ebitda of Gsk Pharmaceuticals Limited in India from Cy 2013 to Fy 2019 (in Billion Indian Rupees)*." Statista, Statista Inc., 18 Jun 2019, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline, EBITDA of GSK Pharmaceuticals Limited in India from CY 2013 to FY 2019 (in billion Indian rupees)* Statista, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/ (last visited April 04, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
